Anavex Reports Fiscal Third Quarter 2017 Financial Results

Anavex Reports Fiscal Third Quarter 2017 Financial Results

NEW YORK – August 7, 2017 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental...

Jefferies 2017 Global Healthcare Conference June 6-9

The Jefferies 2017 Global Healthcare Conference will be taking place June 6-9 in New York City. Following the success of last year’s event, with over 350 participating companies and 2,500 attendees, the conference will again feature an extensive...
Anavex Reports Fiscal Second Quarter 2017 Financial Results

Anavex Reports Fiscal Second Quarter 2017 Financial Results

NEW YORK – May 10, 2017 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental...